我国医院信息系统与国家药品不良反应监测系统对接的需求调研

中国药物警戒 ›› 2016, Vol. 13 ›› Issue (3): 154-158.

我国医院信息系统与国家药品不良反应监测系统对接的需求调研

余超¹,徐玉茗¹,李馨龄²,王玲²,周鹃¹,万凯化¹,徐瑾¹,袁兴东¹

1 江西省药品不良反应监测中心,江西南昌 330046;
2 国家食品药品监督管理总局药品评价中心,北京 100045

收稿日期:2016-01-04 修回日期:2016-04-12 出版日期:2016-03-20 发布日期:2016-04-12
通讯作者: 徐玉茗,男,教授级高级工程师,药事管理。E-mail:490313063@qq.com
作者简介:余超,女,硕士,馆员,药物流行病学。

Demand Investigation of Interconnection between Hospital Information System and National Adverse Drug Reaction Monitoring System in China

YU Chao¹， XU Yu-ming¹， LI Xin-ling²， WANG Ling²， ZHOU Juan¹， WAN Kai-hua¹， XU Jin¹， YUAN Xin-dong¹

1. Jiangxi Center for Adverse Drug Reaction Monitoring, Jiangxi Nanchang 330046, China;
2. Center for Drug Reevaluation, CFDA, Beijing 100045, China

Received:2016-01-04 Revised:2016-04-12 Online:2016-03-20 Published:2016-04-12

摘要/Abstract

摘要： 目的调研国内医院信息系统（HIS）和国家药品不良反应（ADR）系统建设的现状,收集和确定医院对于系统对接功能的需求。方法采用文献研究、意见征求、问卷调查、座谈访谈、现场观摩等方法 ,按地理位置分层抽样法,对黑龙江、上海、重庆、甘肃、云南、江西6个省份的34家医疗机构的进行需求调研。以医院信息化部门负责人、ADR监测人员等为调查对象,共计362人。收到反馈问卷362份。结果 34家三级医院均是非营利性医院,额定床位数均在1 000张以上,在职人员人数平均1 824人,上年度门诊量平均在108万人次以上。76.47%（26/34）的医院主要以手工方式上报ADR报告,且未建院内ADR监测系统。 85.29%的院内HIS系统可进行二次开发。就HIS系统与ADR监测系统连接方式, 64.71%的医院选择布置交换机自动交换方式。对接功能需求主要分为系统维护功能、日常业务功能、ADR查询统计功能、临床用药和决策辅助功能4类,其总体需求率分别为100%、90.33%、80.94%和90.33%。结论本研究确立了以系统维护功能、日常业务功能、 ADR查询统计功能、临床用药决策辅助功能4类需求功能为主的对接系统功能。

关键词: 医院信息系统, 国家药品不良反应监测系统, 对接, 需求

Abstract: Objective To study the current state of construction of domestic hospital information system (HIS) and the national adverse drug reaction monitoring system (NADRMS), and to collect and confirm the demands of hospital for the connection of HIS and NADRMS. Methods The Methods of analyzing literature, consultation, questionnaire survey, interviewing and on-scene observation were used, 34 medical institutions from 6 provinces, namely Heilongjiang, Shanghai, Chongqing, Gansu, Yunnan, and Jiangxi were investigated by stratified sampling method according to geographical location. 362 medical workers were investigated, including heads of hospital information technology department and ADR monitoring personnel, and 362 questionnaires were received. Results 34 tertiary hospitals were all non-profit ones with more than 1 000 rated beds, the average number of in-service staff was 1 824, and average outpatient amount of the prior year was above 1.08 million person-time. 76.47% (26/34) of those hospitals mainly reported ADR reports manually, and didn’t build hospital ADR monitoring system. 85.29% of the hospital HIS were able to do secondary development. On the issue of the type of communicating HIS and NADRMS, 64.71% of the hospital selected the type of automatic exchange through the interchanger. The functional requirements of docking were mainly divided into four categories: the system maintenance, daily service, ADR enquiry and statistics, and clinical application and decision-making assistance, their rates of overall demand were 100%, 90.33%, 80.94% and 100% respectively. Conclusion This paper established functions of docking system that mainly include four types of demand function, namely the system maintenance, daily service, ADR enquiry and statistics, and clinical application and decision-making assistance.

Key words: hospital information system, national adverse drug reaction monitoring system, interconnection, demand

中图分类号:

R994.11
R952

余超,徐玉茗,李馨龄,王玲,周鹃,万凯化,徐瑾,袁兴东. 我国医院信息系统与国家药品不良反应监测系统对接的需求调研[J]. 中国药物警戒, 2016, 13(3): 154-158.

YU Chao， XU Yu-ming， LI Xin-ling， WANG Ling， ZHOU Juan， WAN Kai-hua， XU Jin， YUAN Xin-dong . Demand Investigation of Interconnection between Hospital Information System and National Adverse Drug Reaction Monitoring System in China[J]. Chinese Journal of Pharmacovigilance, 2016, 13(3): 154-158.

参考文献

[1] Huang Y L, Moon J, Segal J B.A comparison of active adverse event surveillance systems worldwide[J].Drug Saf, 2014, 37(8):581-596.
[2] Xie Y M, Liao X, Zhang W, et al. Expert consensus for postmarketing Chinese medicine intensive hospital safety monitoring[J].Chin J Integr Med, 2014, 4.6(6:1-9)
[3] 高源. 应用ASP动态网页技术在医院局域网上建立药品不良反应电子报表[J]. 药学实践杂志,2006,24(5):299-302.
[4] 林洁娜,刘金英,林小玲,等. 药品不良反应临床简报系统的设计和应用[J]. 中国社区医师(医学专业半月刊),2009,11(14):13-14.
[5] 王玲.欧美药物警戒中电子化医疗保健数据的应用研究[J].中国药物警戒,2015, 12(3):156-159.
[6] 庄严,谢邦铁,翁盛鑫,等.基于HIS 的中成药不良反应监测系统设计与思考[J]. 医疗卫生装备,2011,32(12):47-49.
[7] 耿魁魁,刘圣,沈爱宗. 基于医院信息系统开展药物警戒的探索[J]. 中国药物警戒,2012,9(2):77-80.
[8] 王玲.基于医院信息系统开展药品不良反应监测研究[J].中国药物警戒,2015,12 (4):229-231.
[9] 朱长生,邓玲华,李虹影. 医院药品不良反应监测系统的建立和应用[J]. 中国药房,2010,21(5):395-397.
[10] Abrams J Y, Weintraub E S, Baggs J M, et al .Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006 [J]. Vaccine, 2015, 33(2): 382-387.
[11] Geier D A, Kern J K, King P G, et al. A Case-Control Study Evaluating the Relationship Between Thimerosal-Containing Haemophilus influenzae Type b Vaccine Administration and the Risk for a Pervasive Developmental Disorder Diagnosis in the United States [J]. Biol Trace Elem Res, 2015, 163(1-2): 28-38.
[12] 俞明荣,郭正萱. HIS系统与合理用药监测系统[J].中国医药导报, 2009, 6 (2):115-117.
[13] 陆晓彤,刘海涛,张健.基于医院信息系统的肝酶升高药品不良反应自动监测系统研究[J].中国药房, 2012, 23(22):2080-2082.

[1]	杨珍珍, 常成, 高娜, 张晓林, 宋银森, 刘颖, 范天黎. 基于网络药理学和体外研究探讨木犀草素抑制食管鳞状细胞癌的分子机制[J]. 中国药物警戒, 2023, 20(9): 992-1001.
[2]	史香芬, 孙志勇, 张旭锋, 卢晓静, 杜书章, 张晓坚. 基于智能信息管理系统的门诊麻精药品全流程管理[J]. 中国药物警戒, 2023, 20(8): 899-903.
[3]	苏月芬, 郑婧柔, 宫贺, 谢广通, 张洁, 赛春梅. 乳腺结重痛轻凝胶贴膏的成型性及治疗乳腺增生作用机制研究[J]. 中国药物警戒, 2023, 20(7): 783-790.
[4]	余悦华, 赵岩, 卢天公, 孙震晓. 基于EGFR的抗肺腺癌中药筛选及其体外作用研究[J]. 中国药物警戒, 2023, 20(7): 735-741.
[5]	付昌丽, 陆苑, 陈思颖, 王永林, 李勇军, 王爱民, 刘春花. 红禾麻入血成分治疗类风湿性关节炎的作用机制[J]. 中国药物警戒, 2023, 20(2): 171-176.
[6]	王如梦, 郭梓琪, 杨宏新, 杨勇. 基于网络药理学及分子对接探讨荜茇治疗胃癌的作用机制研究[J]. 中国药物警戒, 2023, 20(10): 1121-1128.
[7]	黄艳丽, 谢雁鸣, 王连心, 孙粼希, 刘峘, 庄鋆妮. 真实世界老年患者使用刺五加注射液的临床分析[J]. 中国药物警戒, 2022, 19(9): 935-939.
[8]	苏鑫鑫, 赵晓晓, 谢雁鸣. 榄香烯乳注射液治疗肝癌患者的真实世界联合用药分析[J]. 中国药物警戒, 2022, 19(9): 929-934.
[9]	汪祺, 文海若, 马双成. 以法尼醇X受体为作用靶点的何首乌中肝毒性成分的筛选[J]. 中国药物警戒, 2022, 19(6): 630-634.
[10]	冯群, 姚景春, 李欣, 荆凡波, 张娜, 张贵民. 川乌生物碱类成分致心脏毒性的网络分析与机制预测[J]. 中国药物警戒, 2022, 19(1): 62-68.
[11]	刘枭, 徐银莹, 姜孙旻, 许云. 基于网络药理学和分子对接探讨疏风解毒胶囊治疗新型冠状病毒肺炎可能的作用机制[J]. 中国药物警戒, 2021, 18(2): 115-120.
[12]	黄元, 王成岗, 吴世福, 王玲, 田月洁, 吴晨, 王晓骏. 我国医疗机构药物滥用监测模式需求调查[J]. 中国药物警戒, 2020, 17(9): 607-612.
[13]	姬海南, 李海山, 宋乃宁, 李斌, 隋峰, 李鹰飞, 郭家彬, 贾强, 李桦, 高月, 沈国林. 马兜铃酸I对小鼠肝脏代谢酶的影响研究[J]. 中国药物警戒, 2020, 17(7): 403-407.
[14]	刘伟, 秦柯, 张彦忠, 白素平. 基于网络药理学探讨补骨脂潜在肝毒性机制[J]. 中国药物警戒, 2020, 17(12): 849-855.
[15]	王玲. 基于医院信息系统开展药品不良反应监测研究[J]. 中国药物警戒, 2015, 12(4): 229-231.